Sfoglia per Afferenza Dipartimento di Scienze cliniche applicate e biotecnologiche
Tympanic membrane homografts. Histological findings in a human case.
1982-01-01 Zambonin Zallone, A; Teti, ANNA MARIA; Iurato, S.
Type 1 diabetes mellitus. Comparison between the association with PTPN22 genotype and the association with ACP1-ADA1joint genotype
2014-01-01 Gloria-Bottini, F.; Saccucci, P.; Manca-Bitti, M. L.; Rapini, N.; Verrotti, A.; Neri, A.; Magrini, A.; Bottini, E.
Type 1 diabetes: evidence of interaction between ACP1 and ADA1 gene polymorphisms.
2009-01-01 Patrizia, Saccucci; Maria Luisa Manca Bitti, ; Nunzio, Bottini; Novella, Rapini; Simona, Piccinini; Federica, D’Annibale; Francesco, Chiarelli; VERROTTI di PIANELLA, Alberto; Egidio, Bottini; Fulvia, Gloria-Bottini
Type 4 phosphodiesterases: a possible role in hepatocyte transformation
2018-01-01 Ragusa, Federica; Panera, Nadia; Cardarelli, Silvia; Caioni, Giulia; Alisi, Anna; Giorgi, Mauro; Massimi, Mara
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
2017-01-01 Cesarini, Valeriana; Martini, Maurizio; Vitiani, Lucia Ricci; Gravina, Giovanni Luca; Di Agostino, Silvia; Graziani, Grazia E.; D'Alessandris, Quintino Giorgio; Pallini, Roberto; Larocca, Luigi M.; Rossi, Pellegrino; Jannini, Emmanuele A.; Dolci, Susanna
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations
2004-01-01 Letizia, C; Taranta, A; Migliaccio, S; Caliumi, C; Diacinti, D; Delfini, E; D'Erasmo, E; Iacobini, M; Roggini, M; Albagha, Ome; Ralston, Sh; Teti, ANNA MARIA
Type III B endoleak leading to aortic rupture after endovascular repair: analysis of errors in follow up and treatment
2018-01-01 Leopardi, Marco; Salerno, Alessia; Scarpelli, Pietro; Ventura, Marco
Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells
2013-01-01 Compagnucci, C; Di Siena, S; Bustamante, M B; Di Giacomo, D; Di Tommaso, M; Maccarrone, M; Grimaldi, P; Sette, C
Type-1 and type-2 cannabinoid receptor signalling is involved in the neuroprotectiv eeffect of Saffron of rat retina
2016-01-01 Rapino, C.; Maccarone, R.; Zerti, D.; Di Tommaso, M.; Battista, N.; Di Marco, S.; Bisti, S.; Maccarrone, M.
Type-1 cannabinoid receptor
2018-01-01 Bisogno, T; Maccarrone, M
TYPE-1 CANNABINOID RECEPTOR EFFECT ON HUMAN COLONIC MOTILITY IN PATIENTS WITH SLOW TRANSIT CONSTIPATION AND CONTROLS
2018-01-01 Altomare, A; Guarino, Mpl; Bisogno, T; Cocca, S; Alloni, R; Maccarrone, M; Cicala, M
TYPE-1 CANNABINOID RECEPTOR EFFECT ON HUMAN COLONIC MOTILITY IN PATIENTS WITH SLOW TRANSIT CONSTIPATION AND CONTROLS
2018-01-01 Altomare, A; Bisogno, T; Guarino, M; Cocca, S; Maccarrone, M; Cicala, M
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells
2008-01-01 Bari, M; Oddi, S; De Simone, C; Spagnolo, P; Gasperi, V; Battista, N; Centonze, D; Maccarrone, M
Type-1 Cannabinoid Receptors Reduce Membrane Fluidity of Capacitated Boar Sperm by Impairing Their Activation by Bicarbonate
2011-01-01 Barboni, B; Bernabo, N; Palestini, P; Botto, L; Pistilli, Mg; Charini, M; Tettamanti, E; Battista, N; Maccarrone, M; Mattioli, M
Type-2 cannabinoid receptors in neurodegeneration
2016-01-01 Bisogno, T; Oddi, S; Piccoli, A; Fazio, D; Maccarrone, M
Tyrosine kinase inhibitor CEP-701 blocks NTRK1/NGF receptor and limits invasive capabilities of prostate cancer cells in vitro
2006-01-01 Festuccia, C; Muzi, P; Gravina, GIOVANNI LUCA; Pomante, R; Ventura, L; Millimaggi, D; Speca, S; Dolo, Vincenza; Vicentini, C. AND BOLOGNA M.
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro
2007-01-01 Festuccia, C; Muzi, P; Gravina, GIOVANNI LUCA; Millimaggi, D; Speca, S; Dolo, Vincenza; Ricevuto, Enrico; Vicentini, Carlo; Bologna, Mauro
Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma
2023-01-01 Rango, E.; Di Maria, S.; Zamperini, C.; Poggialini, F.; Crespan, E.; Perini, C.; Sabetta, S.; Saponara, S.; Fusi, F.; Maga, G.; Angelucci, A.; Gaudio, E.; Berton, F.; Schenone, S.; Botta, L.; Dreassi, E.; Botta, M.
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease.
2002-01-01 Recchia, I; Rucci, Nadia; Migliaccio, S; Mackay, ANDREW REAY; Festuccia, C; Bologna, M; Fabbro, D; Susa, M; Teti, A.
Tyrosine kinase Src inhibitors: Potential therapeutic applications
2000-01-01 Susa, M; Teti, ANNA MARIA
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tympanic membrane homografts. Histological findings in a human case. | 1-gen-1982 | Zambonin Zallone, A; Teti, ANNA MARIA; Iurato, S. | |
| Type 1 diabetes mellitus. Comparison between the association with PTPN22 genotype and the association with ACP1-ADA1joint genotype | 1-gen-2014 | Gloria-Bottini, F.; Saccucci, P.; Manca-Bitti, M. L.; Rapini, N.; Verrotti, A.; Neri, A.; Magrini, A.; Bottini, E. | |
| Type 1 diabetes: evidence of interaction between ACP1 and ADA1 gene polymorphisms. | 1-gen-2009 | Patrizia, Saccucci; Maria Luisa Manca Bitti, ; Nunzio, Bottini; Novella, Rapini; Simona, Piccinini; Federica, D’Annibale; Francesco, Chiarelli; VERROTTI di PIANELLA, Alberto; Egidio, Bottini; Fulvia, Gloria-Bottini | |
| Type 4 phosphodiesterases: a possible role in hepatocyte transformation | 1-gen-2018 | Ragusa, Federica; Panera, Nadia; Cardarelli, Silvia; Caioni, Giulia; Alisi, Anna; Giorgi, Mauro; Massimi, Mara | |
| Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome | 1-gen-2017 | Cesarini, Valeriana; Martini, Maurizio; Vitiani, Lucia Ricci; Gravina, Giovanni Luca; Di Agostino, Silvia; Graziani, Grazia E.; D'Alessandris, Quintino Giorgio; Pallini, Roberto; Larocca, Luigi M.; Rossi, Pellegrino; Jannini, Emmanuele A.; Dolci, Susanna | |
| Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations | 1-gen-2004 | Letizia, C; Taranta, A; Migliaccio, S; Caliumi, C; Diacinti, D; Delfini, E; D'Erasmo, E; Iacobini, M; Roggini, M; Albagha, Ome; Ralston, Sh; Teti, ANNA MARIA | |
| Type III B endoleak leading to aortic rupture after endovascular repair: analysis of errors in follow up and treatment | 1-gen-2018 | Leopardi, Marco; Salerno, Alessia; Scarpelli, Pietro; Ventura, Marco | |
| Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells | 1-gen-2013 | Compagnucci, C; Di Siena, S; Bustamante, M B; Di Giacomo, D; Di Tommaso, M; Maccarrone, M; Grimaldi, P; Sette, C | |
| Type-1 and type-2 cannabinoid receptor signalling is involved in the neuroprotectiv eeffect of Saffron of rat retina | 1-gen-2016 | Rapino, C.; Maccarone, R.; Zerti, D.; Di Tommaso, M.; Battista, N.; Di Marco, S.; Bisti, S.; Maccarrone, M. | |
| Type-1 cannabinoid receptor | 1-gen-2018 | Bisogno, T; Maccarrone, M | |
| TYPE-1 CANNABINOID RECEPTOR EFFECT ON HUMAN COLONIC MOTILITY IN PATIENTS WITH SLOW TRANSIT CONSTIPATION AND CONTROLS | 1-gen-2018 | Altomare, A; Guarino, Mpl; Bisogno, T; Cocca, S; Alloni, R; Maccarrone, M; Cicala, M | |
| TYPE-1 CANNABINOID RECEPTOR EFFECT ON HUMAN COLONIC MOTILITY IN PATIENTS WITH SLOW TRANSIT CONSTIPATION AND CONTROLS | 1-gen-2018 | Altomare, A; Bisogno, T; Guarino, M; Cocca, S; Maccarrone, M; Cicala, M | |
| Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells | 1-gen-2008 | Bari, M; Oddi, S; De Simone, C; Spagnolo, P; Gasperi, V; Battista, N; Centonze, D; Maccarrone, M | |
| Type-1 Cannabinoid Receptors Reduce Membrane Fluidity of Capacitated Boar Sperm by Impairing Their Activation by Bicarbonate | 1-gen-2011 | Barboni, B; Bernabo, N; Palestini, P; Botto, L; Pistilli, Mg; Charini, M; Tettamanti, E; Battista, N; Maccarrone, M; Mattioli, M | |
| Type-2 cannabinoid receptors in neurodegeneration | 1-gen-2016 | Bisogno, T; Oddi, S; Piccoli, A; Fazio, D; Maccarrone, M | |
| Tyrosine kinase inhibitor CEP-701 blocks NTRK1/NGF receptor and limits invasive capabilities of prostate cancer cells in vitro | 1-gen-2006 | Festuccia, C; Muzi, P; Gravina, GIOVANNI LUCA; Pomante, R; Ventura, L; Millimaggi, D; Speca, S; Dolo, Vincenza; Vicentini, C. AND BOLOGNA M. | |
| Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro | 1-gen-2007 | Festuccia, C; Muzi, P; Gravina, GIOVANNI LUCA; Millimaggi, D; Speca, S; Dolo, Vincenza; Ricevuto, Enrico; Vicentini, Carlo; Bologna, Mauro | |
| Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma | 1-gen-2023 | Rango, E.; Di Maria, S.; Zamperini, C.; Poggialini, F.; Crespan, E.; Perini, C.; Sabetta, S.; Saponara, S.; Fusi, F.; Maga, G.; Angelucci, A.; Gaudio, E.; Berton, F.; Schenone, S.; Botta, L.; Dreassi, E.; Botta, M. | |
| Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. | 1-gen-2002 | Recchia, I; Rucci, Nadia; Migliaccio, S; Mackay, ANDREW REAY; Festuccia, C; Bologna, M; Fabbro, D; Susa, M; Teti, A. | |
| Tyrosine kinase Src inhibitors: Potential therapeutic applications | 1-gen-2000 | Susa, M; Teti, ANNA MARIA |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile